HDM1002 clinical trials
Also written HDM1002.
How each study uses HDM1002 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the HDM1002 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2024 (7)
| Year | Studies |
|---|---|
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
Repaglinide (1) · Atorvastatin (1) · Empagliflozin (1) · Valsartan (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test HDM1002, phase 3 first.
- Feb 2027A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusPhase 3 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Studies
Open first, then newest update. How each study uses HDM1002 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy SubjectsRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07594847Written as HDM1002 200 mg
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07331389Written as HDM1002
- Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07193459Written as HDM1002 200 mg
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07082114Written as HDM1002 100 mg
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsNot yet recruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06885021Written as HDM1002 200mg, oral, once daily, 52 weeks
- A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy SubjectsNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06608329Written as HDM1002
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06601517Written as HDM1002
- A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy SubjectsRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06576401Written as [14C] HDM1002
- HDM1002 Tablets in Chinese Overweight and Obese Adult SubjectsNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06520540Written as HDM1002 100 mg QD 12weeks
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese AdultsNot yet recruitingPhase 2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06500299Written as HDM1002 100 mg QD
- To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusCompletedPhase 2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06481085Written as HDM1002 50 mg
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy SubjectsStatus unknownPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06562088Written as HDM1002 and rifampicin